Efficacy and safety of anrikefon in patients with pruritus undergoing haemodialysis: multicentre, double blind, randomised placebo controlled phase 3 trial
Authors
Zuo‐Lin Li (ORCID: https://orcid.org/0000-0002-6694-8406)
Efficacy and safety of anrikefon in patients with pruritus undergoing haemodialysis: multicentre, double blind, randomised placebo controlled phase 3 trial
Zuo‐Lin Li, Aimin Zhong, Tianjun Guan, Linghui Zhou et al.
Citations
5 citations
Journal
BMJ
Topics
Dermatology and Skin Diseases
Field-Weighted Citation Impact (FWCI)
10.02
article
Efficacy and safety of anrikefon in patients with pruritus undergoing haemodialysis: multicentre, double blind, randomised placebo controlled phase 3 trial
Qingdao University (CN), Hebei Medical University (CN), Nanchang University (CN), Guiyang Medical University (CN), First Affiliated Hospital of Xiamen University (CN), China National Pharmaceutical Group Corporation (China) (CN), Zhongda Hospital Southeast University (CN), Fourth Hospital of Hebei Medical University (CN), Jiangxi Provincial People's Hospital (CN), Affiliated Hospital of Guizhou Medical University (CN), Affiliated Hospital of Qingdao University (CN), Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (CN), Zhongshan Hospital of Xiamen University (CN), Zhongshan Hospital (CN), Yueyang Second People's Hospital (CN), First Affiliated Hospital of Henan University of Science and Technology (CN), First Hospital of China Medical University (CN), Affiliated Zhongshan Hospital of Dalian University (CN), First People's Hospital of Nanning (CN), Second People’s Hospital of Yibin (CN), Wuxi People's Hospital (CN), Baotou Medical College (CN), First Affiliated Hospital of Nanchang University (CN), First Affiliated Hospital Zhejiang University (CN), China Medical University (CN)